Medifast, Inc. (LON:0K05)

Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of GBP 98.09 million. The enterprise value is -13.12 million.

Market Cap	98.09M
Enterprise Value	-13.12M

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	10.27M
Shares Outstanding	n/a
Shares Change (YoY)	+0.54%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.07M

Valuation Ratios

The trailing PE ratio is 36.96.

PE Ratio	36.96
Forward PE	n/a
PS Ratio	0.28
PB Ratio	0.62
P/TBV Ratio	0.62
P/FCF Ratio	n/a
P/OCF Ratio	32.36
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.94
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	7.42

Financial Position

The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.06.

Current Ratio	4.47
Quick Ratio	3.52
Debt / Equity	0.06
Debt / EBITDA	0.41
Debt / FCF	-5.40
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 1.73% and return on invested capital (ROIC) is 3.58%.

Return on Equity (ROE)	1.73%
Return on Assets (ROA)	2.88%
Return on Invested Capital (ROIC)	3.58%
Return on Capital Employed (ROCE)	5.82%
Revenue Per Employee	695,793
Profits Per Employee	5,266
Employee Count	504
Asset Turnover	1.71
Inventory Turnover	3.60

Taxes

In the past 12 months, Medifast has paid 1.91 million in taxes.

Income Tax	1.91M
Effective Tax Rate	41.84%

Stock Price Statistics

The stock price has decreased by -36.95% in the last 52 weeks. The beta is 0.82, so Medifast's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-36.95%
50-Day Moving Average	13.86
200-Day Moving Average	15.31
Relative Strength Index (RSI)	41.50
Average Volume (20 Days)	198

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	9.41

Income Statement

In the last 12 months, Medifast had revenue of GBP 350.68 million and earned 2.65 million in profits. Earnings per share was 0.24.

Revenue	350.68M
Gross Profit	258.95M
Operating Income	9.48M
Pretax Income	4.56M
Net Income	2.65M
EBITDA	19.48M
EBIT	9.48M
Earnings Per Share (EPS)	0.24

Balance Sheet

The company has 118.74 million in cash and 9.54 million in debt, giving a net cash position of 109.20 million.

Cash & Cash Equivalents	118.74M
Total Debt	9.54M
Net Cash	109.20M
Net Cash Per Share	n/a
Equity (Book Value)	157.66M
Book Value Per Share	15.35
Working Capital	116.97M

Cash Flow

In the last 12 months, operating cash flow was 3.03 million and capital expenditures -4.80 million, giving a free cash flow of -1.77 million.

Operating Cash Flow	3.03M
Capital Expenditures	-4.80M
Free Cash Flow	-1.77M
FCF Per Share	n/a

Margins

Gross margin is 73.84%, with operating and profit margins of 2.70% and 0.76%.

Gross Margin	73.84%
Operating Margin	2.70%
Pretax Margin	1.30%
Profit Margin	0.76%
EBITDA Margin	5.56%
EBIT Margin	2.70%
FCF Margin	n/a

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	5.39%
Buyback Yield	-0.54%
Shareholder Yield	n/a
Earnings Yield	2.71%
FCF Yield	-1.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 5.56 and a Piotroski F-Score of 5.

Altman Z-Score	5.56
Piotroski F-Score	5